Products

Morgan Stanley China Healthcare Hybrid Securities Investment Fund A

Fund Code 002708
Operation Mode Open-end
Fund Category Hybrid
Inception Date 2016-06-30
Custodian Agricultural Bank of China
Benchmark CSI Health Care Index*85%+ChinaBond Composite Index Total Return Index (Within 1 year)*10%+Current Deposit Benchmark Interest Rate*5%
Investment Objective Based on strict disciplined risk management measures, the fund uses an active management strategy and invests in high-quality healthcare relevant stocks to seek excess return and long-term capital appreciation.
Portfolio Allocation Stocks: 60%-95%
Healthcare relevant stocks: ≥ 80% non-cash fund assets
Cash, cash equivalents, and other government bonds that will mature in one year: ≥5%
Risk-Return Characteristic Its expected risk and return are lower than equity funds and higher than bond funds and money market funds.
Portfolio Manager

Mr. Wang Dapeng, Ph.D in Finance at Sun Yat-sen University, certified public accountant (CPA). Previously, he served as a lecturer of finance at Changchun University of Technology’s College of Business Administration, and pharmaceutical industry analyst at Baoying Fund Management Co., Ltd. Mr. Wang joined the company in December 2010 and has served as an analyst, assistant director, deputy director of Research Management Dept., and currently serves as the director and fund manager of Research Management Department.